Thromboprophylaxis in the Fontan Circulation: Long-Awaited Validation
- PMID: 36697139
- DOI: 10.1016/j.jacc.2022.11.029
Thromboprophylaxis in the Fontan Circulation: Long-Awaited Validation
Keywords: aspirin; nonvitamin K oral anticoagulants; single ventricle; warfarin.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Thromboprophylaxis in Patients With Fontan Circulation.J Am Coll Cardiol. 2023 Jan 31;81(4):374-389. doi: 10.1016/j.jacc.2022.10.037. J Am Coll Cardiol. 2023. PMID: 36697138 Free PMC article.
Similar articles
-
No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients.Eur J Cardiothorac Surg. 2016 Nov;50(5):980-987. doi: 10.1093/ejcts/ezw159. Epub 2016 May 26. Eur J Cardiothorac Surg. 2016. PMID: 27229665
-
Pathophysiology of thrombosis and anticoagulation post Fontan surgery.Thromb Res. 2018 Dec;172:204-213. doi: 10.1016/j.thromres.2018.04.011. Epub 2018 Apr 14. Thromb Res. 2018. PMID: 29685556 Review.
-
Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis.Heart. 2015 Nov;101(21):1731-7. doi: 10.1136/heartjnl-2015-307930. Epub 2015 Aug 28. Heart. 2015. PMID: 26319122
-
Coagulation and Anticoagulation in Fontan Patients.Can J Cardiol. 2022 Jul;38(7):1024-1035. doi: 10.1016/j.cjca.2022.01.028. Epub 2022 Feb 3. Can J Cardiol. 2022. PMID: 35122939 Review.
-
Utility of the Total Thrombus-Formation Analysis System as a Tool for Evaluating Thrombogenicity and Monitoring Antithrombotic Therapy in Pediatric Fontan Patients.Pediatr Cardiol. 2023 Jun;44(5):1150-1159. doi: 10.1007/s00246-022-03076-8. Epub 2022 Dec 22. Pediatr Cardiol. 2023. PMID: 36550317
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources